Anti-CD3∈F(ab′)2 Fragments Inhibit T Cell Expansion in Vivo during Graft-Versus-Host Disease or the Primary Immune Response to Nominal Antigen

Journal of Immunology

Volumn 159, Issue 12, 1997, Pages 5821-5833

  Blazar, Bruce R ^a   Jenkins, Marc K ^a   Taylor, Patricia A ^c   White, Jennifer ^a   Panoskaltsis Mortari, Angela ^c   Korngold, Robert ^b   Vallera, Daniel A ^a  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c Box 109 UMHC ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CYTOKINE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CELL CLONE; CYTOLOGY; FEMALE; GENETICS; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; IMMUNOPHENOTYPING; INTERPHASE; INTRAPERITONEAL DRUG ADMINISTRATION; KINETICS; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; SPLEEN; T LYMPHOCYTE SUBPOPULATION; THORACIC DUCT; TRANSGENIC MOUSE; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW TRANSPLANTATION; CLONE CELLS; CYTOKINES; FEMALE; GRAFT VS HOST DISEASE; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; INTERPHASE; ISOANTIGENS; KINETICS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; SPLEEN; T-LYMPHOCYTE SUBSETS; THORACIC DUCT;

EID: 0031573587     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Vallera, D. A., and B. R. Blazar. 1989. T-cell depletion for graft-versus-host disease (GVHD) prophylaxis: a perspective on engraftment in mice and humans. Transplantation 47:751.
2. Martin, P. J., and N. A. Kernan. 1997. T-cell depletion for GVHD prevention in humans. In Graft-vs.-Host Disease. J. Ferrara, H. J. Deeg, and S. J. Burakoff, eds. Marcel Dekker, New York, p. 615.
3. Ash, R. C., J. T. Casper, C. R. Chitambar, R. Hansen, N. Bunin, R. L. Truitt, C. Lawton, K. Murray, J. Hunter, L.-A. Baxter-Lowe, J. L. Gottschall, K. Oldham, T. Anderson, B. Camitta, and J. Menitove. 1990. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N. Engl. J. Med. 322:485.
4. Goldman, J. M., R. P. Gale, M. M. Horowitz, J. C. Biggs, R. E. Champlin, E. Gluckman, R. G. Hoffman, S. J. Jacobsen, A. M. Marmont, P. B. McGlave, A. A. RImm, C. Tozman, B. Speck, S. Tura, and R. S. Weiner. 1988. Bone marrow transplantation for chronic myelongenous leukemia in chronic phase: increased risk of relapse associated with T-cell depletion. Ann. Intern. Med. 108:806.
5. Soderling, C. C. B., C. W. Song, B. R. Blazar, and D. A. Vallera. 1985. A correlation between conditioning and engraftment in recipients of MHC mismatched T-cell depleted murine bone marrow transplants. J. Immunol. 35:941.
6. Martin, P. J., J. A. Hansen, C. D. Buckner, J. E. Sanders, H. J. Deeg, P. Stewart, F. R. Appelbaum, R. Clift, A. Fefer, R. P. Witherspoon, M. S. Kennedy, K. M. Sullivan, N. Flournoy, R. Storb, and E. D. Thomas. 1985. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66:664.
7. Jenkins, M. K., C. Chen, G. Jung, D. L. Mueller, and R. H. Schwartz. 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144:16.
8. Anasetti, C., P. Tan, J. A. Hansen, and P. J. Martin. 1990. Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen. J. Exp. Med. 172:1691.
9. Shi, Y., B. M. Sahai, and D. R. Green. 1989. Cyclosporin A inhibits activation induced cell death in T-cell hybridomas and thymocytes. Nature 339:625.
10. 2 fragments prevent lethal murine graft-versus-host disease induced across the major histocompatibility barrier. J. Immunol. 150:265.
11. Blazar, B. R., P. A. Taylor, and D. A. Vallera. 1994. In vivo or in vitro anti-CD3∈ chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major barrier in mice. J. Immunol. 152:3665.
12. Piguet, P. F., G. E. Grau, B. Allet, and P. Vassalli. 1987. Tumor necrosis factor/ cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J. Exp. Med. 166:1280.
13. Nestel, F. P., K. S. Price, T. A. Seemayer, and W. S. Lapp. 1992. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J. Exp. Med. 175:405.
14. Hoffman, R. A., J. M. Langrehr, S. M. Wren, K. E. Dull, S. T. Ildstad, S. A. McCarthy, and R. L. SImmons. 1993. Characterization of the Immunosuppressive effects of nitric oxide in graft vs host disease. J. Immunol. 151:1508.
15. Falzarano, G., W. Krenger, K. M. Snyder, J. Delmonte, Jr., M. Karandikar, and J. L. M. Ferrara. 1996. Suppression of B-cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-α in mice with acute graft-versus-host disease. Blood 87:2853.
16. Sprent, J., and J. F. Miller. 1976. Effect of recent antigen priming on adoptive Immune responses. III. Antigen-induced selective recruitment of subsets of recirculating lymphocytes reactive to H-2 determinants. J. Exp. Med. 143:585.
17. Sprent, J., and H. von Boehmer. 1976. Activation of T lymphocytes to M locus determinants in vivo. I. Quantitation of T cell proliferation and migration into thoracic duct lymph. Eur. J. Immunol. 6:352.
18. Ferran, C., M. Dy, S. Merite, K. Sheehan, R. Schreiber, F. Leboulenger, P. Landais, J. Bluestone, J. F. Bach, and L. Chatenoud. 1990. Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids. Transplantation 50:642.
19. 2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with the whole monoclonal antibody. Transplantation 49:1117.
20. Blazar, B. R., R. Hirsch, R. E. Gress, S. F. Carroll, and D. A. Vallera. 1991. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment. J. Immunol. 147:1492.
21. 2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation. J. Immunol. 154:5542.
22. + T cells. Transplantation 61:798.
23. 2) anti-CD3 monoclonal antibody. Transplantation 60:1331.
24. Kearney, E., K. Pape, D. Loh, and M. Jenkins. 1994. Visualization of peptide-specific T cell imunity and peripheral tolerance induction in vivo. Immunity 1:327.
25. Blazar, B. R., C. C. B. Soderling, G. C. Koo, and D. A. Vallera. 1988. Absence of a facilitory role for NK 1.1 positive donor cells in engraftment across a major histocompatibility barrier in mice. Transplantation 45:876.
26. + T cells. J. Immunol. 157:3250.
27. + cells. J. Exp. Med. 180:307.
28. Leo, O., M. Foo, D. H. Sachs, L. E. Samuelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
29. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032.
30. Schmid, I., C. H. Uittenbogaart, B. Keld, and J. V. Giorgi. 1994. A rapid method for measuring apoptosis and dual-color immunonuorescence by single laser flow cytometry. J. Immunol. Methods 170:145.
31. Mantel, N. 1966. Evaluation of survival data in two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50:163.
32. Blazar, B. R., P. A. Taylor, G. S. Gray, and D. A. Vallera. 1994. The role of T cell subsets in regulating the in vivo efficacy of CTLA4-Ig in preventing graft-versus-host disease in recipients of fully MHC or minor histocompatibility (miH) only disparate donor inocula. Transplantation 58:1422.
33. 2 in antigen receptor transgenic murine T cells activated by splenic peptide. J. Immunol. 157:3420.
34. Smith, J. A., J. Y. Tso, M. R. Clark, M. S. Cole, and J. A. Bluestone. 1997. Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy. J. Exp. Med. 185:14123.
35. Grundy, J. E., J. D. Shanley, and G. M. Shearer. 1985. Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis. Transplantation. 39:548.
36. Bostrom, L., O. Ringden, J. W. Gratama, N. Jacobsen, F. Zwaan, and B. Nilsson. 1990. The impact of pretransplant herpesvirus serology on acute and chronic graft-versus-host disease: Leukaemia Working Party of the European Group for Bone Marrow Transplantation. Transplant. Proc. 22:206.
37. Lonnqvist, B., O. Ringden, B. Wahren, G. Gahrton, and G. Lundgren. 1984. Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease. Transplantation 38:465.
38. Sullivan, K. M. 1994. Graft-versus-host disease. In Bone Marrow Transplantation. S. J. Forman, K. G. Blume, and E. D. Thomas, eds. Blackwell Scientific Publications, Boston, p. 339.
39. 2 fragments induce a selective T helper dysfunction. J. Immunol. 147:2088.
40. Holda, J. H., T. Maier, and H. N. Claman. 1988. Evidence that IFN-gamma is responsible for natural suppressor activity in GVHD spleen and normal bone marrow. Transplantation 45:772.
41. Wall, D. A., and K. C. Sheehan. 1994. The role of tumor necrosis factor and interferon gamma in graft-versus-host disease and related immunodeficiency. Transplantation 57:273.
42. Krenger, W., G. Falzarano, J. Delmonte, K. M. Snyder, J. C. H. Byon, and J. L. M. Ferrara. 1996. Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease. Blood 88:1113.
43. + lymphoid engraftment. J. Immunol. 152:1004.
44. + donor T cells fail to induce experimental acute graft-versus-host disease. J. Immunol. 155:585.
45. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336:73.
46. Dey, B., K. Swenson, D. A. Pearson, and M. Sykes. 1996. The fate of donor TCR transgenic T cells with known host antigen specificity in a GVHD model. Blood 88 (Suppl 1):676a.
47. Xun, C. Q., J. S. Thompson, C. D. Jennings, S. A. Brown, and M. B. Widmer. 1994. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 83:2360.